Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
14.76
+0.12 (0.82%)
At close: Aug 13, 2025, 4:00 PM
14.85
+0.09 (0.61%)
Pre-market: Aug 14, 2025, 7:21 AM EDT
Alignment Healthcare Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for Alignment Healthcare stock ranges from a low of $13 to a high of $23. The average analyst price target of $17.85 forecasts a 20.93% increase in the stock price over the next year.
Price Target: $17.85 (+20.93%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Alignment Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 3 | 3 | 3 | 3 | 4 | 4 |
Sell | 1 | 1 | 1 | 1 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Sell → Hold Upgrades $9 → $13 | Sell → Hold | Upgrades | $9 → $13 | -11.92% | Jul 31, 2025 |
UBS | UBS | Hold Maintains $16 → $17 | Hold | Maintains | $16 → $17 | +15.18% | May 2, 2025 |
Baird | Baird | Buy Maintains $17 → $22 | Buy | Maintains | $17 → $22 | +49.05% | Apr 15, 2025 |
Stifel | Stifel | Strong Buy Maintains $18 → $23 | Strong Buy | Maintains | $18 → $23 | +55.83% | Apr 8, 2025 |
JP Morgan | JP Morgan | Hold Maintains $14 → $17 | Hold | Maintains | $14 → $17 | +15.18% | Mar 6, 2025 |
Financial Forecast
Revenue This Year
3.88B
from 2.70B
Increased by 43.40%
Revenue Next Year
4.88B
from 3.88B
Increased by 25.87%
EPS This Year
-0.35
from -0.67
EPS Next Year
-0.09
from -0.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.0B | 5.2B | 5.4B | ||
Avg | 3.9B | 4.9B | 5.2B | ||
Low | 3.7B | 4.4B | 4.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 48.5% | 34.2% | 10.7% | ||
Avg | 43.4% | 25.9% | 6.0% | ||
Low | 37.2% | 14.2% | 0.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.28 | 0.11 | 0.45 | ||
Avg | -0.35 | -0.09 | 0.11 | ||
Low | -0.42 | -0.35 | -0.21 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.